Physician profile
Amy Patterson
NPI 1629369475
$1,999.89
in general payments reported to CMS, 2019-2025
18 companies · $599 in 2025
The $599 reported for 2025 was more than what a typical Epilepsy provider received nationally (typical 2025 total: $366).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.44 · 2020: $459 · 2021: $76.16 · 2022: $75.62 · 2023: $168 · 2024: $556 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Upsher-Smith Laboratories LLC | $291.37 | 2023-2025 | |
| Ucb, INC. | $273.62 | 2020-2025 | Briviact, Fintepla, Nayzilam |
| Mallinckrodt Hospital Products INC. | $227.76 | 2020 | |
| Biocodex, INC. | $195.75 | 2023-2025 | Diacomit |
| Neurelis, INC. | $164.81 | 2023-2025 | Valtoco |
| Eisai INC. | $164.75 | 2020-2022 | |
| Acadia Pharmaceuticals INC | $157.01 | 2024 | Daybue |
| Sk Life Science, INC. | $133.56 | 2020-2025 | |
| Azurity Pharmaceuticals, INC. | $68.58 | 2022-2025 | Triptodur, Zonisade |
| Aquestive Therapeutics, INC. | $56.07 | 2019-2021 | |
| Neuropace, INC. | $49.56 | 2019 | |
| Jazz Pharmaceuticals INC. | $47.26 | 2024 | |
| Immedica Pharma US, INC. | $43.60 | 2024 | |
| Itf Therapeutics LLC | $35.85 | 2025 | |
| Supernus Pharmaceuticals, INC. | $33.72 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Pharmaceuticals, INC. | $23.96 | 2025 | |
| Otter Pharmaceuticals, LLC | $18.52 | 2025 | Sympazan |
| Greenwich Biosciences, INC. | $14.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.